...
首页> 外文期刊>Journal of pain and symptom management. >Validity, Reliability, and Responsiveness of the Thai Palliative Care Outcome Scale Staff and Patient Versions Among Cancer Patients
【24h】

Validity, Reliability, and Responsiveness of the Thai Palliative Care Outcome Scale Staff and Patient Versions Among Cancer Patients

机译:泰国姑息治疗结果表明癌症患者患者患者患者的有效性,可靠性和响应性

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundPalliative care is now part of Universal Health Coverage goals. Measurement of person-centered outcomes is central to determining quality and effectiveness. Guidance in psychometrics requires tools applied in new settings to have their properties tested. ObjectivesTo translate staff and patient versions of the Palliative care Outcome Scale (POS, version 2) into Thai, and to determine its psychometric properties among cancer patients in a Thai public hospital. DesignThe Thai POS was subjected to cross-cultural translation: forward translation, backward translation, review by experts, and content validity index measurement. The patient-rated and staff-rated versions were completed by 379 nurses. We tested internal consistency, known-group comparison, responsiveness, and agreement. Setting/ParticipantsAbout 379 Thai cancer patients were admitted to Maharaj Nakorn Chiang Mai Hospital. ResultsWe found good internal consistency (Cronbach's alpha 0.9), good discrimination between known groups (significant difference in scores between high and low performance status groups;Zranged from ?9.95 to ?7.80;P?
机译:BackgroundPaliative Care现在是普遍健康覆盖目标的一部分。以人为本的结果的测量是确定质量和有效性的核心。精神仪表的指导要求在新设置中应用的工具来测试其属性。 Objectivesto将姑息治疗结果规模(POS,版本2)翻译成泰国的员工和患者版本,并确定泰国公立医院癌症患者的心理测量性质。设计泰国POS遭到跨文化翻译:前向翻译,落后翻译,审查经过专家,以及内容有效性指数测量。患者评级和员工额定的版本由379名护士完成。我们测试了内部一致性,已知组比较,响应性和协议。设定/参与者379泰国癌症患者被录取为Maharaj Nakorn Chiang Mai医院。结果我们发现了良好的内部一致性(Cronbach的alpha 0.9),已知组之间的良好歧视(高性能和低性能状态组之间的分数显着差异;从?9.95到?7.80; p?<0.001),良好的响应性(改进时间2;从?14.01到?6.31; p?<?0.001),对评级的良好患者员工协议(加权Kappa范围0.31-0.73)。结论泰国POS有效可靠。这些调查结果使研究人员和临床医生能够在初级研究和常规临床实践中应用POS,以确定干预措施的有效性和改善护理。这是该地区的第一个验证,专为患者和具有晚期疾病的家庭专门设计的多维人为中心的结果措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号